A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I

Mol Vis. 2011 Feb 11:17:456-60.

Abstract

Purpose: To characterize the pathogenic mutations causing mucopolysaccharidosis type I (MPS I) in two Thai patients: one with Hurler syndrome (MPS IH), the most severe form, and the other with Scheie syndrome (MPS IS), the mildest. Both presented with distinctive phenotype including corneal clouding.

Methods: The entire coding regions of the α-L-iduronidase (IDUA) gene were amplified by PCR and sequenced. Functional characterization of the mutant IDUA was determined by transient transfection of the construct into COS-7 cells.

Results: Mutation analyses revealed that the MPS IH patient was homozygous for a previously reported mutation, c.252insC, while the MPS IS patient was found to harbor a novel c.826G>A (p.E276K) mutation. The novel p.E276K mutation was not detected in 100 unaffected ethnic-matched control chromosomes. In addition, the glutamic acid residue at codon 276 was located at a well conserved residue. Transient transfection of the p.E276K construct revealed a significant reduction of IDUA activity compared to that of the wild-type IDUA suggesting it as a disease-causing mutation.

Conclusions: This study reports a novel mutation, expanding the mutational spectrum for MPS I.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acid Sequence
  • Amino Acid Substitution / genetics*
  • Animals
  • Base Sequence
  • COS Cells
  • Child, Preschool
  • Chlorocebus aethiops
  • DNA Mutational Analysis
  • Fatal Outcome
  • Genetic Predisposition to Disease*
  • Humans
  • Iduronidase / chemistry
  • Iduronidase / genetics*
  • Iduronidase / metabolism*
  • Infant
  • Male
  • Molecular Sequence Data
  • Mucopolysaccharidosis I / enzymology*
  • Mucopolysaccharidosis I / genetics*
  • Mutation / genetics*
  • Sequence Alignment
  • Transfection

Substances

  • Iduronidase